Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BioXcellerator

BioXcellerator
2015 FOUNDED
PRIVATE STATUS
PE Growth LATEST DEAL TYPE
$500K LATEST DEAL AMOUNT
1 INVESTORS
Description

Operator of stem cell therapy services. The company offers therapies and skin care creams which are used for various problems such as sports and orthopedic injuries, anti-aging and cosmetic treatments, life-threatening and debilitating diseases such as alzheimer's disease, diabetes and leukemia.

Formerly Known As
Bioscience Americas, LLC
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 2122 East Highland Avenue
  • Suite 265
  • Phoenix, AZ 85016
  • United States

+1 (888) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BioXcellerator’s full profile, request a free trial.

BioXcellerator Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. PE Growth/Expansion 29-Oct-2018 $500K 00.000 Completed Generating Revenue
1. Angel (individual) 26-Oct-2017 00.000 00.000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

BioXcellerator Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Shift4 Capital Merchant Banking Firm Minority 000 0000 000000 0

BioXcellerator Executive Team (4)

Name Title Board
Seat
Contact
Info
Eric Stoffers Chief Executive Officer
Juan Galan Chief Financial Officer
Ben Smith Chief Operating Officer & Chairman
Matthew Marks Chief Strategy Officer

BioXcellerator Board Members (1)

Name Representing Role Since Contact
Info
Ben Smith BioXcellerator Chief Operating Officer & Chairman 000 0000